NO20092359L - Aminoalkoholderivater og deres terapeutiske anvendelse - Google Patents
Aminoalkoholderivater og deres terapeutiske anvendelseInfo
- Publication number
- NO20092359L NO20092359L NO20092359A NO20092359A NO20092359L NO 20092359 L NO20092359 L NO 20092359L NO 20092359 A NO20092359 A NO 20092359A NO 20092359 A NO20092359 A NO 20092359A NO 20092359 L NO20092359 L NO 20092359L
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- ring
- ch2oh
- optionally substituted
- ch2or6
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C219/20—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
- C07C219/22—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Ophthalmology & Optometry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrane Compounds (AREA)
Abstract
Forbindelse med formel (1): (1) omfattende farmasøytisk akseptable salter derav, hvor R1 er aryl eller heteroaryl eventuelt substituert med R8; R2 er H eller alkyl eller CH2 (når den utgjør en del av en ring med R3, R4 eller R5); R3 er H, alkyl, CH2OH eller CH2OR6 og kan være del av en ring med R2; R4 er H, alkyl, CH2OH eller CH2OR6 og kan være del av en ring med R2; R5 er H, alkyl, CH2OH eller CH2OR6 og kan være del av en ring med R2; R6 er H, alkyl, COH, COOR9, CON(R9)2, COR9, COR10, COR11, P(O)nR9, P(O)nR10, S(O)nR10 eller S(O)nR9 og kan være del av en ring med R2, R3, R4 eller R5; R7 er H, alkyl, COOR9, COOR11, COR9 eller CON(R9)2 og kan være del av en ring med R2, R3, R4, R5 eller R6; R8 er alkyl, CF3, OR9, OCOR9, CONH2, CN, F, Cl, Br, I, N(R9)2, NO2, NHCHO, NHCONH2, NHSO2R9, CON(R9)2, S(O)nR9, CH2OH eller OCON(R9)2; R9 er H, alkyl eller cykloalkyl; R10 er aryl eller heteroaryl (eventuelt substituert med R8) eller en fire- til syv-leddet ring (som eventuelt er substituert med R8 og kan inneholde ett eller flere ytterligere heteroatomer valgt fra listen over O, S(O)n og NR9); R11 er alkyl eventuelt substituert med R8 eller R10; og n er 0, 1 eller 2; forutsatt at når R3, R4 eller R5 er CH2OH, så er R6 ikke H, og at når R7 er H og R3, R4 og R5 er alkyl, så er R6 ikke H. Er av terapeutisk nytte ved behandling av en lidelse forbundet med T-celleproliferasjon, eller som blir mediert av pro- og/eller anti-inflammatoriske cytokiner.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0624757.1A GB0624757D0 (en) | 2006-12-12 | 2006-12-12 | Novel compounds |
PCT/GB2007/004752 WO2008071948A2 (en) | 2006-12-12 | 2007-12-12 | Aminoalcohol derivatives and their therapeutic use |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20092359L true NO20092359L (no) | 2009-07-08 |
Family
ID=37711970
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20092359A NO20092359L (no) | 2006-12-12 | 2009-06-19 | Aminoalkoholderivater og deres terapeutiske anvendelse |
Country Status (14)
Country | Link |
---|---|
US (1) | US20100076068A1 (no) |
EP (2) | EP2118050A2 (no) |
JP (1) | JP5225287B2 (no) |
KR (1) | KR20090088442A (no) |
CN (1) | CN101573325A (no) |
AU (1) | AU2007331337A1 (no) |
BR (1) | BRPI0720284A2 (no) |
CA (1) | CA2672238A1 (no) |
GB (1) | GB0624757D0 (no) |
IL (1) | IL199178A0 (no) |
MX (1) | MX2009006246A (no) |
NO (1) | NO20092359L (no) |
WO (1) | WO2008071948A2 (no) |
ZA (1) | ZA200903942B (no) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102635931B1 (ko) * | 2016-12-14 | 2024-02-13 | 에스케이바이오팜 주식회사 | 가려움증의 예방, 경감 또는 치료를 위한 카바메이트 화합물의 용도 |
GB201714736D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
GB201714734D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
GB201714740D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
GB201714745D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH246387A (de) * | 1945-06-12 | 1946-12-31 | H Dr Herzog | Verfahren zur Herstellung eines Ephedrinderivates. |
US2900415A (en) * | 1954-12-14 | 1959-08-18 | Lakeside Lab Inc | Synthesized antispasmodic compounds |
US4166452A (en) | 1976-05-03 | 1979-09-04 | Generales Constantine D J Jr | Apparatus for testing human responses to stimuli |
JPS609713B2 (ja) * | 1976-10-08 | 1985-03-12 | 大塚製薬株式会社 | カルボスチリル誘導体 |
US4256108A (en) | 1977-04-07 | 1981-03-17 | Alza Corporation | Microporous-semipermeable laminated osmotic system |
DE2817494A1 (de) * | 1977-05-03 | 1978-11-09 | Continental Pharma | Aminoalkohol-derivat |
US4638070A (en) * | 1978-12-21 | 1987-01-20 | Continental Pharma | Heterocyclic amino-alcohol derivatives |
US4265874A (en) | 1980-04-25 | 1981-05-05 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
FR2555576B1 (fr) * | 1983-11-25 | 1986-06-13 | Lafon Labor | Derives de n-(methoxyphenacyl)-amine, utilisation notamment en therapeutique et procede de preparation |
IT1222986B (it) * | 1987-10-23 | 1990-09-12 | Texcontor Ets | Derivati dell'efedrina esterificata aventi attivita' antiulcera prolungata nel tempo |
WO1992003131A1 (en) * | 1990-08-13 | 1992-03-05 | G.D. Searle & Co. | Use of heterocyclic amino-alcohol compounds for treatment of cns diseases |
US5264459A (en) * | 1992-07-13 | 1993-11-23 | Arch Development Corporation | Use of β-adrenergic agonists to treat patients with demyelinating or autoimmune diseases |
US6337328B1 (en) * | 1999-03-01 | 2002-01-08 | Sepracor, Inc. | Bupropion metabolites and methods of use |
US6646135B1 (en) * | 1999-06-23 | 2003-11-11 | Roche Vitamins Inc. | Continuous process for the enantioselective hydrogenation of alpha ketocarbonyl compounds |
US6560347B2 (en) * | 2000-12-19 | 2003-05-06 | Samsung Electro-Mechanics Co., Ltd. | Multi actuator |
US20040002546A1 (en) * | 2001-09-15 | 2004-01-01 | Eric Altschuler | Methods for treating crohn's and other TNF associated diseases |
AU2005281495A1 (en) | 2004-09-07 | 2006-03-16 | Sosei R & D Ltd. | The treatment of inflammatory disorders and pain |
IL166149A0 (en) * | 2005-01-05 | 2006-01-15 | Hadasit Med Res Service | Use of ezetimibe and amiodarone in protection against beta-amyloid neurotoxicity |
EP1865779A4 (en) * | 2005-03-21 | 2008-06-04 | Vicus Therapeutics Spe 1 Llc | COMPOSITIONS AND METHODS FOR ENHANCING CACHEXIA |
DE602006016934D1 (de) * | 2005-04-06 | 2010-10-28 | Adamas Pharmaceuticals Inc | Verfahren und zusammensetzungen zur behandlung von zns-erkrankungen |
EP1719507B1 (en) * | 2005-04-13 | 2010-07-14 | Astion Development A/S | Beta-2 adrenoceptor agonists for treating connective tissue diseases of the skin |
GB0519274D0 (en) * | 2005-09-21 | 2005-11-02 | Arakis Ltd | The treatment of neurodegenerative diseases |
GB0526123D0 (en) * | 2005-12-22 | 2006-02-01 | Univ Gent | Synephrine derivatives useful as anti-inflammatory agents |
GB0604822D0 (en) * | 2006-03-09 | 2006-04-19 | Arakis Ltd | The treatment of inflammatory disorders and pain |
GB0604824D0 (en) * | 2006-03-09 | 2006-04-19 | Arakis Ltd | The treatment of inflammatory disorders |
-
2006
- 2006-12-12 GB GBGB0624757.1A patent/GB0624757D0/en not_active Ceased
-
2007
- 2007-12-12 BR BRPI0720284-9A patent/BRPI0720284A2/pt not_active IP Right Cessation
- 2007-12-12 EP EP07848496A patent/EP2118050A2/en not_active Withdrawn
- 2007-12-12 AU AU2007331337A patent/AU2007331337A1/en not_active Abandoned
- 2007-12-12 CN CNA2007800458639A patent/CN101573325A/zh active Pending
- 2007-12-12 CA CA002672238A patent/CA2672238A1/en not_active Abandoned
- 2007-12-12 US US12/517,272 patent/US20100076068A1/en not_active Abandoned
- 2007-12-12 KR KR1020097014285A patent/KR20090088442A/ko not_active Application Discontinuation
- 2007-12-12 MX MX2009006246A patent/MX2009006246A/es not_active Application Discontinuation
- 2007-12-12 JP JP2009540849A patent/JP5225287B2/ja not_active Expired - Fee Related
- 2007-12-12 ZA ZA200903942A patent/ZA200903942B/xx unknown
- 2007-12-12 WO PCT/GB2007/004752 patent/WO2008071948A2/en active Application Filing
- 2007-12-12 EP EP12174501.2A patent/EP2518049A3/en not_active Withdrawn
-
2009
- 2009-06-04 IL IL199178A patent/IL199178A0/en unknown
- 2009-06-19 NO NO20092359A patent/NO20092359L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP2518049A2 (en) | 2012-10-31 |
CN101573325A (zh) | 2009-11-04 |
BRPI0720284A2 (pt) | 2014-01-28 |
IL199178A0 (en) | 2010-03-28 |
CA2672238A1 (en) | 2008-06-19 |
JP5225287B2 (ja) | 2013-07-03 |
WO2008071948A2 (en) | 2008-06-19 |
KR20090088442A (ko) | 2009-08-19 |
EP2118050A2 (en) | 2009-11-18 |
ZA200903942B (en) | 2010-08-25 |
WO2008071948A3 (en) | 2008-07-31 |
JP2010512378A (ja) | 2010-04-22 |
AU2007331337A1 (en) | 2008-06-19 |
US20100076068A1 (en) | 2010-03-25 |
MX2009006246A (es) | 2009-07-16 |
EP2518049A3 (en) | 2013-07-10 |
GB0624757D0 (en) | 2007-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2497807C2 (ru) | Карбазольные соединения и терапевтические применения соединений | |
NO20092359L (no) | Aminoalkoholderivater og deres terapeutiske anvendelse | |
CO6321269A2 (es) | Derivados de benzoxazinona que actuan como agonistas de receptores adrenergicos beta 2 para el tratamiento de transtornos respiratorios | |
RU2015133171A (ru) | Бензиламиновые производные | |
TW200745032A (en) | Novel heterobicyclic derivatives | |
RU2007116038A (ru) | Циклические диарилмочевины, используемые в качестве ингибиторов тирозинкиназы | |
ATE537169T1 (de) | Piperidin- und piperazinderivate als p2x3- antagonisten | |
RU2006146070A (ru) | Циннамидное соединение | |
ATE390415T1 (de) | Chinoxalinderivate als inhibitoren der neutrophilelastase und deren verwendung | |
JP2010526129A5 (no) | ||
SE0302487D0 (sv) | Novel compounds | |
CO6311077A2 (es) | Derivados de 1-(4-hidroxi-fenil)-1h-indol como ligandos novedosos de receptor de estrógeno | |
PE20090770A1 (es) | Derivados de benzoxazolona | |
MX2009008465A (es) | Nuevas 2-aminooxazolinas como ligandos de taar1. | |
NZ586082A (en) | Indole compounds and methods for treating visceral pain | |
CO6260089A2 (es) | Activadores de guanilato ciclasas solubles | |
MX2010006202A (es) | Derivados de oxindol substituidos por amidometil y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina. | |
RS54700B1 (en) | INDAZOLE DERIVATIVES SUBSTITUTED WITH BENZODIOXINIL | |
DE602005016775D1 (de) | Heterocyclische, ein azol enthaltende sulfonamidinhibitoren der beta-amyloid-produktion | |
PE20090606A1 (es) | Nuevos inhibidores de catepsina c y uso | |
NO20055655L (no) | Anvendelse av azetidinkarboksamidderivater i terapi | |
AR059328A1 (es) | Derivados de antranilamida-2-amino-heteroareno-carboxamida, un proceso para su obtencion, composiciones farmaceuticas que los contienen y el uso de estos compuestos para la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por cetp | |
PE20090592A1 (es) | Nuevos derivados de piperazina-amida | |
EA200801494A1 (ru) | Производные оксадиазола с активностью crth2 рецептора | |
DE602004028902D1 (de) | Triazinderivate als uv-absorber |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |